Thomas Babcock, D.O.’88, Ph.D., was among the authors of the article “Aiming for remission in adults with attention-deficit/hyperactivity disorder: the primary care goal,” published in February in Postgraduate Education. He is associate director of scientific publications, medical affairs, with Shire Pharmaceuticals in Wayne, PA.
Thomas F. Babcock, D.O.’88, Ph.D.
Feb 18, 2015 | Updated Feb 18, 2015
